17:27 EST Ovid Therapeutics (OVID) files to sell 125.06M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVID:
- Ovid Therapeutics Stockholders Approve Key Proposals
- Ovid Therapeutics initiated with a Buy at Roth Capital
- Ovid Therapeutics appoints Kaufmann as Chief Medical Officer
- Ovid Therapeutics price target raised to $2 from $1.50 at H.C. Wainwright
- Leerink bullish on Ovid Therapeutics, initiates with an Outperform